0000899243-19-028374.txt : 20191202 0000899243-19-028374.hdr.sgml : 20191202 20191202205729 ACCESSION NUMBER: 0000899243-19-028374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191202 FILED AS OF DATE: 20191202 DATE AS OF CHANGE: 20191202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hasara Garrison J. CENTRAL INDEX KEY: 0001510349 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13467 FILM NUMBER: 191264417 MAIL ADDRESS: STREET 1: 324 S. HYDE PARK AVENUE STREET 2: SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibitor Therapeutics, Inc. CENTRAL INDEX KEY: 0001042418 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 541641133 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE STREET 2: SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 BUSINESS PHONE: (813) 864-2559 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE STREET 2: SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 FORMER COMPANY: FORMER CONFORMED NAME: HedgePath Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130816 FORMER COMPANY: FORMER CONFORMED NAME: COMMONWEALTH BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 19970714 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-02 0 0001042418 Inhibitor Therapeutics, Inc. INTI 0001510349 Hasara Garrison J. 4830 W. KENNEDY BLVD., SUITE 600 TAMPA FL 33609 0 1 0 0 CFO and Treasurer Common Stock 2019-12-02 4 P 0 13500 0.07 A 3972544 D The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at a per share price equal to $0.07 and $0.068. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Garrison J. Hasara 2019-12-02